Adicet Bio (ACET) Current Assets (2017 - 2026)
Adicet Bio's Current Assets came in at $120.76 million for Q2 2026, down 5.5% from $127.74 million a year earlier and down 13.8% from the prior quarter.
Adicet Bio (ACET) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Adicet Bio's Current Assets was $160.93 million, down 10.7% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
- Going back by year, Current Assets was $180.14 million in FY2024 (+11.0%), $162.27 million in FY2023 (-37.8%), $261.04 million in FY2022 (-7.6%) and $282.44 million in FY2021 (+181.5%).
- The five-year range for quarterly Current Assets is $106.49 million (Q3 2025) to $285.74 million (Q3 2022).
- Year-over-year, Current Assets has declined for six consecutive quarters, with an average decline of 16.8% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q4 2021 (growth of 181.5%), and the weakest in Q3 2025 (a decline of 48.4%).
- Business Quant data shows ACET's Current Assets at $140.07 million (Q1 2026), $160.93 million (Q4 2025) and $106.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Adicet Bio | 45.67 Mn | -471.74 Mn | - | 120.76 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.76 Mn |
| Mar 31, 2026 | 140.07 Mn |
| Dec 31, 2025 | 160.93 Mn |
| Sep 30, 2025 | 106.49 Mn |
| Jun 30, 2025 | 127.74 Mn |
| Mar 31, 2025 | 153.56 Mn |
| Dec 31, 2024 | 180.14 Mn |
| Sep 30, 2024 | 206.32 Mn |
| Jun 30, 2024 | 228.35 Mn |
| Mar 31, 2024 | 250.35 Mn |
| Dec 31, 2023 | 162.27 Mn |
| Sep 30, 2023 | 185.88 Mn |
| Jun 30, 2023 | 208.66 Mn |
| Mar 31, 2023 | 234.81 Mn |
| Dec 31, 2022 | 261.04 Mn |
| Sep 30, 2022 | 285.74 Mn |
| Jun 30, 2022 | 264.09 Mn |
| Mar 31, 2022 | 281.53 Mn |
| Dec 31, 2021 | 282.44 Mn |
| Sep 30, 2021 | 199.03 Mn |
Adicet Bio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ACET&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ACET", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ACET&period=max&api_key=YOUR_API_KEY");
const data = await res.json();